Episode 103 - Health tech innovating amidst a pandemic - James Reinstein of Saranas

James Reinstein, Saranas president and CEO, who has a long career in health tech innovation, joined Saranas at the very beginning of the pandemic last year. In spite of the challenges, he’s led the company through a $12.8 million series B round and into commercialization. He joins the show today to discuss what’s next for Saranas and its Early Bird bleed detection technology.